Format

Send to

Choose Destination
See comment in PubMed Commons below
Transplantation. 2004 May 15;77(9):1457-9.

Oral cyclosporine but not tacrolimus reduces renal transplant blood flow.

Author information

1
Department of Renal Medicine, University of Sydney, Westmead Hospital, Sydney, NSW, Australia. Brian_Nankivell@wsahs.nsw.gov.au

Abstract

BACKGROUND:

Calcineurin inhibitors are important immunosuppressive agents, but cause nephrotoxicity.

METHODS:

Instantaneous intra-renal transplant hemodynamics were assessed in 22 patients using quantitative cineloop color Doppler imaging after dosing with microemulsion cyclosporine (CSA) or tacrolimus (TAC).

RESULTS:

CSA dosing resulted in renal hypoperfusion, with a mean relative reduction of 43%+/-20% (range 22-76%) in maximal fractional area (MFA) of color pixels to nadir, compared to baseline. The mean effect occurred 1.1+/-0.9 hr (median 1 hr) after CSA dosing and was abrogated by calcium channel blockers (P <0.05). The main renal artery velocities, resistive index and small vessel perfusion were unchanged, suggestive of medium-sized arteries mediated vasoconstriction. In contrast, TAC did not alter renal vascularity (2.3+/-4.0% absolute reduction of MFA color pixels vs. 10.7+/-6.5% with CSA, P <0.01).

CONCLUSION:

CSA, but not TAC, induces phasic hypoperfusion of variable severity within small to medium sized intra-renal arteries soon after dosing, mitigated by calcium channel blockade.

PMID:
15167607
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center